Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brammeld, Js"'
Autor:
Brammeld, Js, Thorpe, H, Garcia, Ma, Price, S, Young, J, Pfeifer, M, Lupo, B, Yusa, K, Trusolino, L, Garnett, M, Bertotti, A, Bakal, C, Mcdermott, U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______970::f12cc606bcaf8ab2328006485beff63e
https://hdl.handle.net/2318/1885603
https://hdl.handle.net/2318/1885603
Autor:
Pfeifer M; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK.; Leibniz-Institute of Virology (LIV) and University hospital Hamburg-Eppendorf (UKE), Hamburg, Germany., Brammeld JS; Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Price S; Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Pilling J; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Bhavsar D; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Farcas A; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Bateson J; Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Sundarrajan A; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Miragaia RJ; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Guan N; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Arnold S; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Tariq L; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Grondine M; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Talbot S; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Guerriero ML; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., O'Neill DJ; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Young J; Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Company C; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Dunn S; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Thorpe H; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Martin MJ; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Maratea K; Clinical Pharmacology & Safety, BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Barrell D; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Ahdesmaki M; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Mettetal JT; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Brownell J; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., McDermott U; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK. ultan.mcdermott@astrazeneca.com.
Publikováno v:
Communications biology [Commun Biol] 2024 Apr 24; Vol. 7 (1), pp. 497. Date of Electronic Publication: 2024 Apr 24.
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
Autor:
Petljak M; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Alexandrov LB; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK; Department of Cellular and Molecular Medicine and Department of Bioengineering, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA., Brammeld JS; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Price S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Wedge DC; Oxford Big Data Institute, Old Road Campus, Oxford OX3 7LF, UK; Oxford NIHR Biomedical Research Centre, Oxford, OX4 2PG, UK., Grossmann S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Dawson KJ; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Ju YS; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea., Iorio F; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK; European Molecular Biology Laboratory - European Bioinformatics Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Tubio JMC; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK; Mobile Genomes and Disease, Molecular Medicine and Chronic Diseases Centre (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain; The Biomedical Research Centre (CINBIO), Universidade de Vigo, Vigo 36310, Spain., Koh CC; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Georgakopoulos-Soares I; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Rodríguez-Martín B; Mobile Genomes and Disease, Molecular Medicine and Chronic Diseases Centre (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain; The Biomedical Research Centre (CINBIO), Universidade de Vigo, Vigo 36310, Spain., Otlu B; Department of Cellular and Molecular Medicine and Department of Bioengineering, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA., O'Meara S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Butler AP; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Menzies A; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Bhosle SG; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Raine K; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Jones DR; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Teague JW; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Beal K; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Latimer C; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., O'Neill L; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Zamora J; Mobile Genomes and Disease, Molecular Medicine and Chronic Diseases Centre (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain; The Biomedical Research Centre (CINBIO), Universidade de Vigo, Vigo 36310, Spain., Anderson E; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Patel N; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Maddison M; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Ng BL; Cytometry Core Facility, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Graham J; Cytometry Core Facility, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Garnett MJ; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., McDermott U; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Nik-Zainal S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK; Department of Medical Genetics, The Clinical School, University of Cambridge, Cambridge, CB2 0QQ, UK., Campbell PJ; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Stratton MR; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK. Electronic address: mrs@sanger.ac.uk.
Publikováno v:
Cell [Cell] 2019 Mar 07; Vol. 176 (6), pp. 1282-1294.e20.
Autor:
Iorio F; European Molecular Biology Laboratory - European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK. francesco.iorio@sanger.ac.uk.; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK. francesco.iorio@sanger.ac.uk.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SD, UK. francesco.iorio@sanger.ac.uk., Garcia-Alonso L; European Molecular Biology Laboratory - European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SD, UK., Brammeld JS; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK., Martincorena I; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK., Wille DR; GlaxoSmithKline, Gunnels Wood Rd, Stevenage Herts, SG1 2NY, UK.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SD, UK., McDermott U; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK., Saez-Rodriguez J; European Molecular Biology Laboratory - European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK. saezrodriguez@gmail.com.; Joint Research Centre for Computational Biomedicine (JRC-COMBINE), RWTH Aachen University, Faculty of Medicine, MTZ Pauwelstrasse 19, Aachen, 52074, Germany. saezrodriguez@gmail.com.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SD, UK. saezrodriguez@gmail.com.
Publikováno v:
Scientific reports [Sci Rep] 2018 Apr 30; Vol. 8 (1), pp. 6713. Date of Electronic Publication: 2018 Apr 30.
Autor:
Brammeld JS; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Petljak M; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Martincorena I; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Williams SP; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Alonso LG; European Molecular Biology Laboratory - European Bioinformatics Institute, Cambridge CB10 1SA, United Kingdom., Dalmases A; Pathology Department, Hospital del Mar, 08003 Barcelona, Spain., Bellosillo B; Pathology Department, Hospital del Mar, 08003 Barcelona, Spain., Robles-Espinoza CD; Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Campus Juriquilla, Santiago de Querétaro 76230, Mexico., Price S; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Barthorpe S; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Tarpey P; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Alifrangis C; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Bignell G; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Vidal J; Cancer Research Program, FIMIM and Medical Oncology Department, Hospital del Mar, 08003 Barcelona, Spain., Young J; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Stebbings L; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Beal K; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Stratton MR; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Saez-Rodriguez J; European Molecular Biology Laboratory - European Bioinformatics Institute, Cambridge CB10 1SA, United Kingdom.; RWTH Aachen University Hospital, 52062 Aachen, Germany., Garnett M; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom., Montagut C; Cancer Research Program, FIMIM and Medical Oncology Department, Hospital del Mar, 08003 Barcelona, Spain., Iorio F; European Molecular Biology Laboratory - European Bioinformatics Institute, Cambridge CB10 1SA, United Kingdom., McDermott U; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom.
Publikováno v:
Genome research [Genome Res] 2017 Apr; Vol. 27 (4), pp. 613-625. Date of Electronic Publication: 2017 Feb 08.